HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitis.

AbstractOBJECTIVE:
Antineutrophil cytoplasmic antibody-associated vasculitis is an important cause of endstage renal disease. Our aim was to investigate how the underlying vasculitis diagnosis may influence outcomes following renal transplant.
METHODS:
We undertook a retrospective cohort study of patients who underwent renal transplant at the Johns Hopkins Hospital between 1999 and 2008.
RESULTS:
Detailed followup data were available for 11 patients with Wegener's granulomatosis (WG) and 6 with microscopic polyangiitis (MPA), representing 799 patient-months of observation. Patients with WG remained on hemodialysis longer (and may have had slightly worse renal outcomes following transplant) than patients with MPA. Four patients with WG experienced adverse events following renal transplant: 2 experienced rejection and 2 vasculitis flare. Among the patients with MPA, there was 1 episode of rejection and no vasculitis flare.
CONCLUSION:
Whether outcomes following renal transplant may be influenced by the underlying diagnosis of vasculitis merits further study.
AuthorsDuvuru Geetha, Mark Haas, Edward S Kraus, Hamid Rabb, Philip Seo
JournalThe Journal of rheumatology (J Rheumatol) Vol. 37 Issue 8 Pg. 1705-8 (Aug 01 2010) ISSN: 0315-162X [Print] Canada
PMID20516028 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Adult
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Blood Vessels (pathology)
  • Cohort Studies
  • Female
  • Granulomatosis with Polyangiitis (blood, pathology, surgery)
  • Humans
  • Kidney Failure, Chronic (blood, pathology, surgery)
  • Kidney Function Tests
  • Kidney Transplantation
  • Male
  • Microscopic Polyangiitis (blood, pathology, surgery)
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: